Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.24.1.u1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Beginning Balance (in shares) at Dec. 31, 2021   9,669,217     334,800 725,426
Beginning Balance at Dec. 31, 2021 $ (6,611,457) $ 967 $ 33,221,505 $ (39,844,531) $ 3,348 $ 7,254
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 2,602,175   2,602,175      
Cancellation and exchange of convertible note in connection with reverse capitalization (in shares)   5,299,546        
Cancellation and exchange of convertible note in connection with reverse capitalization 14,548,914 $ 530 14,548,384      
Conversion of Series A preferred stock in connection with reverse recapitalization (in shares)   4,756,470     (334,800)  
Conversion of Series A preferred stock in connection with reverse recapitalization 0 $ 476 2,872   $ (3,348)  
Conversion of Series B preferred stock in connection with reverse recapitalization (in shares)   10,306,055       (725,426)
Conversion of Series B preferred stock in connection with reverse recapitalization 0 $ 1,030 6,224     $ (7,254)
Reverse recapitalization with Cleantech Acquisition Corp, net (in shares)   6,619,490        
Reverse recapitalization with Cleantech Acquisition Corp, net (669,242) $ 662 (669,904)      
Earnout shares placed in escrow (in shares)   7,499,993        
Earnout shares placed in escrow 0 $ 750 (750)      
Issuance of common stock for PIPE Investment (in shares)   3,100,000        
Issuance of common stock for PIPE Investment $ 31,000,000 $ 310 $ 30,999,690      
Equity issuance costs (12,582,000)   (12,582,000)      
Net loss $ (28,260,571)     (28,260,571)    
Ending Balance (in shares) at Dec. 31, 2022   47,250,771     0 0
Ending Balance at Dec. 31, 2022 27,819 $ 4,725 $ 68,128,196 (68,105,102) $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 4,427,073   4,427,073      
Exercise of stock options (in shares) 227,837 227,837        
Exercise of stock options $ 421,175 $ 23 421,152      
Exercise of warrants (in shares)   165,713        
Exercise of warrants 338,055 $ 16 338,039      
Exercise of RSUs (in shares)   501,437        
Vesting of RSUs 0 $ 51 (51)      
Settlement of liquidated damages (in shares)   1,890,066        
Settlement of liquidated damages $ 3,685,629 $ 189 3,685,440      
Cancellation and exchange of convertible note in connection with reverse capitalization (in shares) 92,040          
Net loss $ (50,686,601)     (50,686,601)    
Ending Balance (in shares) at Dec. 31, 2023   50,035,824     0 0
Ending Balance at Dec. 31, 2023 $ (41,786,850) $ 5,004 $ 76,999,849 $ (118,791,703) $ 0 $ 0